BioHarvest Sciences Inc.

Stage 4 · Declining · week 42

As of Oct 22, 2026, BioHarvest Sciences is in Stage 4, the downtrend phase, now in week 42 (since Dec 26, 2025). It closed at $1.68, 85.9% below its 52-week high and below its 200-day average, which is falling.

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. More about the company

$1.68

+0.48% today

$38.1M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is BHST early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 17w

S2 19w

S2 32w

S4 43w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 17w → S1 5w → S2 19w → S3 11w → S4 13w → S1 7w → S2 4w → S3 2w → S4 5w → S1 1w → S2 32w → S3 5w → S4 43w current

Total tracked: 165 weeks across 13 stage runs.

BHST among Packaged Foods52nd of 65 by relative strength

All 65 →

Stocks in Packaged Foods ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	DARDarling Ingredients Inc.	Stage 2 · wk 10	93	−9.3%
2	WESTWestrock Coffee Company	Stage 2 · wk 4	93	+19.9%
3	HLFHerbalife Ltd.	Stage 1 · wk 2	89	+14.9%
4	SENEBSeneca Foods Corp. Class B	Stage 2 · wk 34	87	−4.8%
5	CENTCentral Garden & Pet Company	Stage 3 · wk 6	84	+14.3%
6	SENEASeneca Foods Corp. Class A	Stage 2 · wk 38	81	−8.3%
7	CENTACentral Garden & Pet Company Class A	Stage 3 · wk 6	81	+13.6%
8	SJMThe J.M. Smucker Company	Stage 2 · wk 17	78	+9.0%
…52	BHSTBioHarvest Sciences Inc.	Stage 4 · wk 42	9	+15.1%

vs 52W High

-85.9%

$1.45 lo$11.90 hi

85.9% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 42

1w13w26w

Week 42, extended decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-49.8%

200 DMA: $3.35 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.43x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↗ ⇈

Short-term trend rising gently, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+15.1%

-12.5%

-61.4%

YTD

-67.8%

-84.8%

Scan Membership

Breakout Watch

Latest: 2025-04-14

5 appearances in last 60 days. First seen: 2021-12-27.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 42 · Vol 0.43x

2026-10-21S4

Wk 42 · Vol 0.21x

2026-10-20S4

Wk 41 · Vol 0.32x

2026-10-19S4

Wk 41 · Vol 0.52x

2026-10-16S4

Wk 41 · Vol 0.16x

2026-10-15S4

Wk 41 · Vol 0.30x

2026-10-14S4

Wk 41 · Vol 0.44x

2026-10-13S4

Wk 40 · Vol 0.74x

2026-10-12S4

Wk 40 · Vol 0.21x

2026-10-09S4

Wk 40 · Vol 0.37x

2026-10-08S4

Wk 40 · Vol 0.36x

2026-10-07S4

Wk 40 · Vol 0.31x

Moving averages & range

50 DMA

$1.75

200 DMA

$3.35

52W High

$11.90

52W Low

$1.45

5D Low

$1.67

Resistance levels (recent highs)

20d High

$1.85

60d High

$2.56

120d High

$4.21

250d High

$11.51

Next resistance

+10.1%

to 20d High

ROE

-142.5%

Profit margin -31.2%

Dividend Yield

0.00%

P/B 1.9

BioHarvest Sciences: quick answers

What stage is BioHarvest Sciences in?

As of Oct 22, 2026, BioHarvest Sciences (BHST) is in Stage 4, the downtrend phase. It entered Stage 4 on Dec 26, 2025 and is in week 42. What the four stages mean

Is BioHarvest Sciences in an uptrend?

No. BioHarvest Sciences is in a Stage 4 downtrend. It trades 49.8% below its 200-day average, which is falling.

How far is BioHarvest Sciences from its 52-week high?

BioHarvest Sciences closed at $1.68 on Oct 22, 2026, 85.9% below its 52-week high of $11.90. Its 52-week low is $1.45.

How has BioHarvest Sciences performed over the past year?

As of Oct 22, 2026, BioHarvest Sciences is down 84.8% over the past year and down 67.8% so far in 2026.

Which sector and industry is BioHarvest Sciences in?

BioHarvest Sciences is in the Packaged Foods industry, part of the Consumer Staples sector.

About this companyConsumer Staples· Packaged Foods

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.